These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33922783)

  • 21. Long-term neurodevelopment outcome of caffeine versus aminophylline therapy for apnea of prematurity.
    Khurana S; Shivakumar M; Sujith Kumar Reddy GV; Jayashree P; Ramesh Bhat Y; Lewis LES
    J Neonatal Perinatal Med; 2017; 10(4):355-362. PubMed ID: 29286928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants].
    Zhao Y; Tian X; Liu G
    Zhonghua Er Ke Za Zhi; 2016 Jan; 54(1):33-6. PubMed ID: 26791921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical effect and safety of different maintenance doses of caffeine citrate in treatment of apnea in very low birth weight preterm infants: a prospective randomized controlled trial].
    Zhang X; Zhang HT; Lyu Y; Wang LF; Yang ZY
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jun; 21(6):558-561. PubMed ID: 31208509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic basis of apnoea of prematurity and caffeine treatment response: role of adenosine receptor polymorphisms: genetic basis of apnoea of prematurity.
    Kumral A; Tuzun F; Yesilirmak DC; Duman N; Ozkan H
    Acta Paediatr; 2012 Jul; 101(7):e299-303. PubMed ID: 22462821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caffeine and supplemental oxygen effectively suppress periodic breathing with only minor effects during long episodes of apnoea in preterm infants.
    Seppä-Moilanen M; Andersson S; Rantakari K; Mikkola K; Kirjavainen T
    Acta Paediatr; 2019 Mar; 108(3):443-451. PubMed ID: 30118174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Archimedes: Does caffeine treatment for apnoea of prematurity improve neurodevelopmental outcome in later life?
    Schmidt B; Roberts RS; Davis P; Doyle LW;
    Arch Dis Child; 2011 Aug; 96(8):784. PubMed ID: 21377992
    [No Abstract]   [Full Text] [Related]  

  • 27. Question 1 Does caffeine treatment for apnoea of prematurity improve neurodevelopmental outcome in later life?
    Winckworth LC; Powell E
    Arch Dis Child; 2010 Sep; 95(9):757-9. PubMed ID: 20716677
    [No Abstract]   [Full Text] [Related]  

  • 28. Caffeine therapy for apnea of prematurity.
    Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
    N Engl J Med; 2006 May; 354(20):2112-21. PubMed ID: 16707748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of doxapram on episodes of apnoea, bradycardia and hypoxaemia in preterm infants.
    Poets CF; Darraj S; Bohnhorst B
    Biol Neonate; 1999 Oct; 76(4):207-13. PubMed ID: 10473894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caffeine for apnea of prematurity: a neonatal success story.
    Kreutzer K; Bassler D
    Neonatology; 2014; 105(4):332-6. PubMed ID: 24931325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of caffeine therapy for apnea of prematurity.
    Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
    N Engl J Med; 2007 Nov; 357(19):1893-902. PubMed ID: 17989382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caffeine for the Treatment of Apnea in the Neonatal Intensive Care Unit: A Systematic Overview of Meta-Analyses.
    Alhersh E; Abushanab D; Al-Shaibi S; Al-Badriyeh D
    Paediatr Drugs; 2020 Aug; 22(4):399-408. PubMed ID: 32488731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caffeine versus theophylline for apnea in preterm infants.
    Henderson-Smart DJ; Steer PA
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD000273. PubMed ID: 20091506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. It is time for a rethink about caffeine therapy for apnoea of prematurity.
    Prakash R
    Acta Paediatr; 2023 Sep; 112(9):2006-2007. PubMed ID: 36644929
    [No Abstract]   [Full Text] [Related]  

  • 35. Sex-based differences in apnoea of prematurity: A retrospective cohort study.
    Bairam A; Laflamme N; Drolet C; Piedboeuf B; Shah PS; Kinkead R;
    Exp Physiol; 2018 Oct; 103(10):1403-1411. PubMed ID: 29974527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caffeine Therapy in Preterm Infants: The Dose (and Timing) Make the Medicine.
    Rostas SE; McPherson C
    Neonatal Netw; 2019 Nov; 38(6):365-374. PubMed ID: 31712401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High versus standard dose caffeine for apnoea: a systematic review.
    Vliegenthart R; Miedema M; Hutten GJ; van Kaam AH; Onland W
    Arch Dis Child Fetal Neonatal Ed; 2018 Nov; 103(6):F523-F529. PubMed ID: 29437799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. National and international guidelines for neonatal caffeine use: Are they evidenced-based?
    Eichenwald EC
    Semin Fetal Neonatal Med; 2020 Dec; 25(6):101177. PubMed ID: 33214064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.
    Schoen K; Yu T; Stockmann C; Spigarelli MG; Sherwin CM
    Paediatr Drugs; 2014 Apr; 16(2):169-77. PubMed ID: 24399614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical effect of different maintenance doses of caffeine citrate in the treatment of preterm infants requiring assisted ventilation: a pilot multicenter study.
    Yang Y; Lu KY; Cheng R; Zhou Q; Fang GD; Li H; Shao J; Wang HY; Li ZY; Liu SL; Li ZG; Cai JL; Xue M; Chen XQ; Pan ZJ; Gao Y; Huang L; Li HY; Song L; Wang SN; Shu GH; Wu W; Yu MZ; Xu Z; Li HX; Xu Y; Bao ZD; Wu XP; Ye L; Dong XP; Yin QG; Yin XP; Zhou JJ;
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Mar; 24(3):240-248. PubMed ID: 35351252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.